Joyful Balance Holistic Healing Pllc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 171 Portland Rd Ste 4, Bridgton, ME 04009 Phone: 207-803-8888 |
Liane Muller, D.o., Pa Clinic/Center Medicare: Medicare Enrolled Practice Location: 63 Main St, Suite A, Bridgton, ME 04009 Phone: 207-647-2440 Fax: 207-647-3775 |
Dfd Russell Medical Center Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 25 Hospital Dr, Bridgton, ME 04009 Phone: 207-524-3501 Fax: 207-647-4000 |
News Archive
The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).
New research gives information in order to understand safety, efficacy and mechanisms of action of a new cardiac therapy.
A virus discovered last year in a rare form of skin cancer has also been found in people with the second most common form of skin cancer among Americans, according to researchers at the Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
A new study published on the preprint server medRxiv* by researchers from Iceland and the U.S. shows how treatment with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) does not raise angiotensin-converting enzyme 2 (ACE2) levels in human serum – and cautions against the discontinuation of these drugs among patients affected with coronavirus disease (COVID-19).
Coronary angioplasty improves survival in all patients with out of hospital cardiac arrest, according to research presented at the Acute Cardiac Care Congress 2012. The study was presented by Dr Annamaria Nicolino from the Santa Corona General Hospital in Pietra Ligure, Italy.
› Verified 6 days ago